Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, announced the ...
EQT Life Sciences is pleased to announce that the LSP 7 fund has invested in Noema Pharma ("the Company"). The clinical-stage biotech company headquartered in Basel, Switzerland is developing a ...
STOCKHOLM--Swedish buyout group EQT led a series B funding extension for Swiss biotech company Noema Pharma. Noema Pharma is developing a pipeline of therapeutics that address central nervous system ...
Noema Pharma, a Swiss biotech targeting debilitating central nervous system (CNS) disorders, has announced the successful ...
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
EGM was convened today on 11 December 2024. In accordance with the Nomination Committee's proposals, David Meek was elected as new member of the Board of Directors and Chair of the Board of Directors ...
NaturVet announces Willie Post as the Executive Director of U.S. Sales. With over 35 years of experience in business and sales leadership at renowned companies like Pfizer, Johnson & Johnson, Reckitt ...
Michael Nagle / Bloomberg via Getty Images EQT shares rose after the natural gas producer said Blackstone’s credit and insurance business is buying a $3.5 billion stake in its midstream assets ...
Shares of NYSE:EQT opened at $45.28 on Tuesday. The stock’s 50 day moving average price is $39.14 and its 200 day moving average price is $37.16. The company has a debt-to-equity ratio of 0.65 ...
Shares of NYSE EQT opened at $45.29 on Monday. The stock has a market cap of $27.02 billion, a P/E ratio of 53.92 and a beta of 1.06. The firm has a 50 day moving average price of $38.93 and a two ...
EQT forms a midstream JV with Blackstone Credit, raising $3.5B, valuing the deal at $8.8B. Proceeds to reduce EQT's debt, targeting $9B in net debt by year-end 2024. As per the deal, BXCI will ...